Rizatriptan

Rizatriptan

SCHEMBL28815652

CN(C)CCc1c[nH]c2ccc(Cn3cncn3)cc12.Cl

nearest known ligand 0.98

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

HTR1BHTR1D

The experimentally established mechanism targets of Rizatriptan. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 9)

geneUniProtsupporting neighboursconfidence
HTR1D known ✓ P28221 5/20 0.98
HTR1B known ✓ P28222 5/20 0.98
HTR1A P08908 12/20 0.98
HTR2C P28335 9/20 0.98
ADRA2C P18825 1/20 0.98
HTR2A P28223 1/20 0.98
HRH1 P35367 1/20 0.98
HTR2B P41595 1/20 0.98
HTR5A P47898 3/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Rizatriptan SCHEMBL29407208 0.99 HTR1A (1.00) HTR1AHTR2CHTR1DHTR1BADRA2C
Rizatriptan SCHEMBL26662 0.99 HTR1A (1.00) HTR1AHTR2CHTR1DHTR1BADRA2C
Rizatriptan SCHEMBL12802834 0.99 HTR1A (1.00) HTR1AHTR2CHTR1DHTR1BADRA2C
Rizatriptan SCHEMBL2231061 0.93 HTR1A (0.88) HTR1AHTR2CHTR1DHTR1BADRA2C
Rizatriptan SCHEMBL28840728 0.93 HTR1A (0.88) HTR1AHTR2CHTR1DHTR1BADRA2C
Rizatriptan SCHEMBL8809846 0.92 HTR1A (0.86) HTR1AHTR2CHTR1DHTR1BADRA2C
Rizatriptan SCHEMBL8809854 0.92 HTR1A (0.86) HTR1AHTR2CHTR1DHTR1BADRA2C
Rizatriptan SCHEMBL1650947 0.92 HTR1A (0.86) HTR1AHTR2CHTR1DHTR1BADRA2C
Rizatriptan SCHEMBL3462253 0.91 HTR1A (0.85) HTR1AHTR2CHTR1DHTR1BADRA2C
Rizatriptan SCHEMBL2326617 0.90 HTR1A (0.83) HTR1AHTR2CHTR1DHTR1BADRA2C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113081991-B Pharmaceutical dosage forms and uses thereof 南京三迭纪医药科技有限公司 2022-07-15 CN disclosed